Trial Profile
Tolerability and Pharmacokinetics of a New P-Glycoprotein Inhibitor, HM30181, in Healthy Korean Male Volunteers: Single- and Multiple-Dose Randomized, Placebo-Controlled Studies
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Feb 2012
Price :
$35
*
At a glance
- Drugs HM 30181A (Primary)
- Indications Cancer
- Focus Adverse reactions; Pharmacokinetics
- 25 Jan 2012 New trial record